Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Dec 1;144(6):1568–1580. doi: 10.1084/jem.144.6.1568

The binding of human lactoferrin to mouse peritoneal cells

PMCID: PMC2190488  PMID: 1003104

Abstract

Human iron-saturated Lf (FeLf), which was labeled with 125I or 50Fe, was found to combine with the membrane of mouse peritoneal cells (MPC) which consisted of 70% macrophages. The following experimental data suggested the involvement of a specific receptor. (a) The binding of FeLf to MPC reached a saturation point. (b) The binding of radioactive FeLf was inhibited by preincubating the cells with cold FeLf but not with human Tf, human aggregated and nonaggregated IgG, or beef heart cytochrome c (c) Succinylation and carbamylation of FeLf resulted in a loss of its inhibiting activity on the binding of radioactive FeLf. Removal of neuraminic acid from FeLf increased its inhibitory activity. (d) The ability of apoLf to inhibit the binding of FeLf to MPC was significantly lower than that of FeLf. The existence of a Lf receptor capable of concentrating Lf released from neutrophils on the membrane of macrophages could explain the apparent blockade of the release of iron from the reticuloendothelial system, which accounts for the hyposideremia of inflammation. A receptor for FeLf was also found on mouse peritoneal lymphocytes. The affinity constant of FeLf for both lymphocytes and macrophages was 0.9 X 12(6) liter/mol. Howerver, macrophages bound three times more FeLf molecules (20 X 10(6)) per cell than did lymphocytes (7 X 10(6)).

Full Text

The Full Text of this article is available as a PDF (825.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend W. P., Mannik M. The macrophage receptor for IgG: number and affinity of binding sites. J Immunol. 1973 Jun;110(6):1455–1463. [PubMed] [Google Scholar]
  2. Baggiolini M., De Duve C., Masson P. L., Heremans J. F. Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med. 1970 Mar 1;131(3):559–570. doi: 10.1084/jem.131.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bluard-Deconinck J. M., Masson P. L., Osinski P. A., Heremans J. F. Amino acid sequence of cysteic peptides of lactoferrin and demonstration of similarities between lactoferrin and transferrin. Biochim Biophys Acta. 1974 Oct 9;365(2):311–317. doi: 10.1016/0005-2795(74)90002-6. [DOI] [PubMed] [Google Scholar]
  4. Bullen J. J., Rogers H. J., Leigh L. Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J. 1972 Jan 8;1(5792):69–75. doi: 10.1136/bmj.1.5792.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. COHN Z. A., BENSON B. THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY. J Exp Med. 1965 Jan 1;121:153–170. doi: 10.1084/jem.121.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fielding J., Speyer B. E. Iron transport intermediates in human reticulocytes and the membrane binding site of iron-transferrin. Biochim Biophys Acta. 1974 Sep 23;363(3):387–396. doi: 10.1016/0005-2736(74)90077-7. [DOI] [PubMed] [Google Scholar]
  7. Fillet G., Cook J. D., Finch C. A. Storage iron kinetics. VII. A biologic model for reticuloendothelial iron transport. J Clin Invest. 1974 Jun;53(6):1527–1533. doi: 10.1172/JCI107703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hekman A. Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility. Biochim Biophys Acta. 1971 Dec 28;251(3):380–387. doi: 10.1016/0005-2795(71)90126-7. [DOI] [PubMed] [Google Scholar]
  10. Lane R. S. Localization of transferrin in human and rat liver by fluorescent antibody technique. Nature. 1967 Jul 8;215(5097):161–162. doi: 10.1038/215161a0. [DOI] [PubMed] [Google Scholar]
  11. MONTREUIL J., TONNELAT J., MULLET S. [Preparation and properties of lactosiderophilin (lactotransferrin) of human milk]. Biochim Biophys Acta. 1960 Dec 18;45:413–421. doi: 10.1016/0006-3002(60)91478-5. [DOI] [PubMed] [Google Scholar]
  12. Malmquist J., Johansson B. G. Interaction of lactoferrin with agar gels and with Trypan Blue. Biochim Biophys Acta. 1971 Apr 27;236(1):38–46. doi: 10.1016/0005-2795(71)90146-2. [DOI] [PubMed] [Google Scholar]
  13. Malmquist J. Serum lactoferrin in leukaemia and polycythaemia vera. Scand J Haematol. 1972;9(4):305–310. doi: 10.1111/j.1600-0609.1972.tb00945.x. [DOI] [PubMed] [Google Scholar]
  14. Masson P. L., Heremans J. F. Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction. Eur J Biochem. 1968 Dec 5;6(4):579–584. doi: 10.1111/j.1432-1033.1968.tb00484.x. [DOI] [PubMed] [Google Scholar]
  15. Masson P. L., Heremans J. F., Prignot J. J., Wauters G. Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax. 1966 Nov;21(6):538–544. doi: 10.1136/thx.21.6.538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Masson P. L., Heremans J. F., Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med. 1969 Sep 1;130(3):643–658. doi: 10.1084/jem.130.3.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Oram J. D., Reiter B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta. 1968 Dec 23;170(2):351–365. doi: 10.1016/0304-4165(68)90015-9. [DOI] [PubMed] [Google Scholar]
  18. Querinjean P., Masson P. L., Heremans J. F. Molecular weight, single-chain structure and amino acid composition of human lactoferrin. Eur J Biochem. 1971 Jun 11;20(3):420–425. doi: 10.1111/j.1432-1033.1971.tb01408.x. [DOI] [PubMed] [Google Scholar]
  19. Rümke P., Visser D., Kwa H. G., Hart A. A. Radio-immuno assay of lactoferrin in blood plasma of breast cancer patients, lactating and normal women; prevention of false high levels caused by leakage from neutrophile leucocytes in vitro. Folia Med Neerl. 1971 Aug-Sep;14(4):156–168. [PubMed] [Google Scholar]
  20. SCHADE A. L. IRON UPTAKE BY ERYTHROPOIETIC AND OTHER TISSUES FROM "NATIVE" SERUM SIDEROPHILIN AND FROM ISOLATED "PURIFIED" SIDEROPHILIN. Farmaco Sci. 1964 Feb;19:185–202. [PubMed] [Google Scholar]
  21. Van Snick J. L., Masson P. L., Heremans J. F. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med. 1974 Oct 1;140(4):1068–1084. doi: 10.1084/jem.140.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES